Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SREK1 interacting protein 1 (SREK1IP1)
- Target
- SREK1IP1
- Molecular classification
- Other (splicing regulator, zinc finger domain-containing protein)
01
Overview
SREK1 interacting protein 1 (SREK1IP1) is a lysine-rich zinc finger protein that interacts with splicing factors (notably SRrp86), and is predicted to function as a splicing regulator, enabling nucleic acid and zinc ion binding activity. It is involved in multiple aspects of RNA splicing and mRNA processing and may play a role in cellular survival. SREK1IP1 is classified as a non-canonical splicing regulatory protein rather than a classical receptor or enzyme and does not appear to be a direct therapeutic target, nor does it currently have any known drug interactions, biomarker status, or established disease associations.
- Other names
- SFRS12IP1P18SRPp18 splicing regulatory proteinFLJ36754SFRS12-interacting protein 1SREK1-interacting protein 1Splicing regulatory protein of 18 kDaSrsf12ip13110031B13RikRG1305356splicing regulatory glutamine/lysine-rich protein 1 interacting protein 1
02
Biological functions
RNA splicingmRNA processingregulation of gene expressionnucleic acid bindingzinc ion bindingcontrol of cellular survival
03
Disease associations
None specifically described in current sources (no direct association with cancer, inflammation, neurodegenerative disease, etc.)
Beyond the preview
Go deeper on SREK1 interacting protein 1 (SREK1IP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SREK1 interacting protein 1 (SREK1IP1).